Oklahoma Attorney General Gentner Drummond
Oklahomans who bought generic drugs between 2009-2019 may qualify for compensation
OKLAHOMA CITY (Feb. 6, 2026) – Attorney General Gentner Drummond announced today that two major pharmaceutical companies will pay $17.85 million to settle allegations that they illegally worked together to raise prices on generic prescription drugs.
The settlement involves Lannett Company, Inc. and Bausch Health companies and is part of an ongoing multistate litigation against dozens of companies for illegal agreements to fix prices for generic drugs.
“These drug companies colluded to jack up prices on medications that Oklahoma families depend on,” said Drummond. “Their illegal scheming cost our citizens and state healthcare programs millions of dollars. We’re holding them accountable and will continue fighting to protect Oklahoma consumers.”
Oklahoma joined 47 other states and territories in this settlement. Both companies have agreed to cooperate with ongoing investigations and implement internal reforms to prevent future price-fixing.
The drugs included in the scheme span all types including tablets, capsules, creams and ointments and classes including antibiotics, anti-depressants, contraceptives and non-steroidal anti-inflammatory drugs. They treat a range of diseases and conditions from basic infections to diabetes, cancer, epilepsy, multiple sclerosis, HIV, ADHD and more. In some instances, the coordinated price increases were over 1,000 percent.
Lannett will pay more than $13 million and Bausch will pay $4 million under the two settlements, which will be distributed to impacted consumers.
Oklahomans who purchased certain generic prescription drugs between May 2009 and December 2019 may be eligible for compensation. Consumers can determine their eligibility by calling 866-290-0182, emailing info@AGGenericDrugs.com, or visiting www.AGGenericDrugs.com.
Get Local News!
